28 web-programmer-developer-"Prof" Postdoctoral positions at University of Southern Denmark
Sort by
Refine Your Search
-
background. About SDU and Odense SDU was founded in 1966 and now has more than 27,000 students, almost 20% of whom are from abroad. It has more than 3,800 employees, and 115 different study programmes in
-
programmes in the fields of the humanities, social sciences, natural sciences, health sciences, and engineering. Its main campus is located in Odense, the third largest city in Denmark, but is present also in
-
). The successful candidate will contribute to the Nudge2Green research project, applying software development and AI methods to design digital nudging tools that promote sustainable consumer behavior in food choices
-
contributes to aging-related diseases and aims to develop therapeutic strategies to mitigate its harmful effects while preserving its beneficial functions. The lab also works on cellular rejuvenation through
-
candidate will develop experimental research performing magneto-optical spectroscopy combined with electronic transport to investigate light-matter interactions in 2D materials. Our goal is to create new
-
. We offer an attractive and inspiring working environment with dedicated and highly skilled people. There is a formalized teaching program dedicated to methodological aspects of pharmacoepidemiological
-
an open, international team with flexible work organization and support of individual development. The Centre is involved in a variety of national and European projects and features a strong network of
-
regulatory mechanisms in development and disease and will support Professor Tiwari in smooth running of the laboratory at various levels. The group employs cutting-edge molecular biology, epigenetics and
-
the possibility of extension. The postdoc will lead research on deciphering gene regulatory mechanisms underlying brain development and its disruption in neurodevelopmental disorders. The group addresses these aims
-
development, and guidance within the field tumor-immunology and cell therapy. The position focuses on in vivo reprogramming of immune cells using chimeric antigen receptor (CAR) constructs against glioblastoma